To Our Stockholders, Employees and Friends: In 2013, Gilead made major advances across our areas of therapeutic focus, significantly expanded the company’s global reach,delivered medicines to a record number of patients and announced the strongest revenues in the company’s history.
Please find attached the Annual Report 2013 ….
-
Annual Report 2013